Literature DB >> 23584896

Effect of bone marrow mesenchymal stem cells on hepatocellular carcinoma in microcirculation.

Peng Gong1, Yingxin Wang, Yulin Wang, Shi Jin, Haifeng Luo, Jing Zhang, Haidong Bao, Zhongyu Wang.   

Abstract

This study aims t explore the effect and application of bone marrow mesenchymal stem cells (BMSCs) on hepatocellular carcinoma in microcirculation by observing the angiogenesis of hepatocellular carcinoma in transplanted area. BMSCs were isolated and cultured primarily using the method of whole bone marrow culture and identifying surface antigens of third-generation bone marrow-derived mesenchymal stem cells using flow cytometry. Hepatoma cells cultured with BMSCs-conditioned medium (BMSCs-CM) were assayed using the cell proliferation rate of the MTT method. Nude mice were divided into control group (group A), BMSCs cell transplantation group (group B), HepG-2 cell group (group C), and combined BMSCs and HepG-2 cell cotransplanted group (group D). The result showed that the microvascular density was not significantly different in groups A and B. However, the microvascular density at 14 days was higher than 0 day in group C (P < 0.05). In group D, the microvascular density at 14 days was higher than that of 7 and 0 days (P < 0.05) and 7 days was higher than 0 days (P < 0.05). It was showed that the microvascular density did not get significant difference at 0 and 7 days in the four groups (P > 0.05). But the microvascular density of group C was higher than groups A and B at 14 days (P < 0.05), group D was higher than groups A and B at 14 days (P < 0.05) and group D was higher than group C at 14 days (P < 0.05). BMSCs could promote the growth of microvascular in hepatoma cells in a transplanted area.

Entities:  

Mesh:

Year:  2013        PMID: 23584896     DOI: 10.1007/s13277-013-0749-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  23 in total

1.  Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo.

Authors:  Wei Zhu; Wenrong Xu; Runqiu Jiang; Hui Qian; Miao Chen; Jiabo Hu; Weike Cao; Chongxu Han; Yongchang Chen
Journal:  Exp Mol Pathol       Date:  2005-10-07       Impact factor: 3.362

2.  Stat bite: worldwide cervical and uterine cancer incidence and mortality, 2002.

Authors: 
Journal:  J Natl Cancer Inst       Date:  2006-08-02       Impact factor: 13.506

Review 3.  Use of hepatocyte and stem cells for treatment of post-resectional liver failure: are we there yet?

Authors:  Tarek M Ezzat; Dipok K Dhar; Philip N Newsome; Massimo Malagó; Steven W M Olde Damink
Journal:  Liver Int       Date:  2011-04-19       Impact factor: 5.828

4.  Chemokines mediate mesenchymal stem cell migration toward gliomas in vitro.

Authors:  Feng Xu; Jinlong Shi; Bin Yu; Wei Ni; Xing Wu; Zhikai Gu
Journal:  Oncol Rep       Date:  2010-06       Impact factor: 3.906

Review 5.  Recent advances in liver stem cell therapy.

Authors:  Tatiana Kisseleva; Elia Gigante; David A Brenner
Journal:  Curr Opin Gastroenterol       Date:  2010-07       Impact factor: 3.287

6.  The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model.

Authors:  I Debergh; N Van Damme; P Pattyn; M Peeters; W P Ceelen
Journal:  Br J Cancer       Date:  2010-02-02       Impact factor: 7.640

7.  Long-term superior performance of a stem cell/hepatocyte device for the treatment of acute liver failure.

Authors:  Hiroshi Yagi; Biju Parekkadan; Kazuhiro Suganuma; Alejandro Soto-Gutierrez; Ronald G Tompkins; Arno W Tilles; Martin L Yarmush
Journal:  Tissue Eng Part A       Date:  2009-11       Impact factor: 3.845

8.  Effects of bone marrow and hepatocyte transplantation on liver injury.

Authors:  Biao Zhang; Mitsuhiro Inagaki; Bojian Jiang; Masaaki Miyakoshi; Jun Arikura; Katsuhiro Ogawa; Shinichi Kasai
Journal:  J Surg Res       Date:  2009-01-06       Impact factor: 2.192

Review 9.  Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment.

Authors:  Maartje A J van den Broek; Steven W M Olde Damink; Cornelis H C Dejong; Hauke Lang; Massimo Malagó; Rajiv Jalan; Fuat H Saner
Journal:  Liver Int       Date:  2008-07       Impact factor: 5.828

Review 10.  Cytokine networks in solid human tumors: regulation of angiogenesis.

Authors:  R D Leek; A L Harris; C E Lewis
Journal:  J Leukoc Biol       Date:  1994-10       Impact factor: 4.962

View more
  4 in total

1.  Paracrine factors of human fetal MSCs inhibit liver cancer growth through reduced activation of IGF-1R/PI3K/Akt signaling.

Authors:  Yulyana Yulyana; Ivy A W Ho; Kian Chuan Sia; Jennifer P Newman; Xin Yi Toh; Berwini B Endaya; Jerry K Y Chan; Massimiliano Gnecchi; Hung Huynh; Alexander Y F Chung; Kiat Hon Lim; Hui Sun Leong; Narayanan Gopalakrishna Iyer; Kam Man Hui; Paula Y P Lam
Journal:  Mol Ther       Date:  2015-01-26       Impact factor: 11.454

2.  Bone marrow mesenchymal stem cells suppress metastatic tumor development in mouse by modulating immune system.

Authors:  Lei Zhang; Xiao San Su; Jun Song Ye; Yi Yin Wang; Zheng Guan; Yan Feng Yin
Journal:  Stem Cell Res Ther       Date:  2015-03-24       Impact factor: 6.832

Review 3.  Genetic modification by overexpression of target gene in mesenchymal stromal cell for treating liver diseases.

Authors:  Chenxia Hu; Lingfei Zhao; Lanjuan Li
Journal:  J Mol Med (Berl)       Date:  2021-01-02       Impact factor: 4.599

Review 4.  Multipotent mesenchymal stromal cells play critical roles in hepatocellular carcinoma initiation, progression and therapy.

Authors:  Zeli Yin; Keqiu Jiang; Rui Li; Chengyong Dong; Liming Wang
Journal:  Mol Cancer       Date:  2018-12-28       Impact factor: 27.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.